Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
Tarih
2009Yazar
Giobbie-Hurder, Anita
Gelber, Richard D.
Price, Karen N.
Üst veri
Tüm öğe kaydını gösterÖzet
Background Aromatase inhibitors provide superior disease control when compared with tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer.
Koleksiyonlar
- Makale [92796]